Quick Answer
MAIA Biotechnology, Inc. reported Net Income of -$22.40 million for fiscal year 2025.
MAIA Biotechnology, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$22.40M | +3.7% |
| 2024 | -$23.25M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.90M | -225.4% | -66.5% |
| June 30, 2025 | -$5.35M | +39.8% | -18.4% |
| March 31, 2025 | -$4.52M | +44.0% | -65.1% |
| September 30, 2024 | -$2.74M | — | +69.2% |
| June 30, 2024 | -$8.88M | — | -10.1% |
| March 31, 2024 | -$8.07M | — | -144.0% |
| June 30, 2022 | -$3.31M | +3.6% | +3.6% |
| June 30, 2021 | -$3.43M | — | — |
- MAIA Biotechnology, Inc. showed an increase of +3.7% in Net Income compared to the prior fiscal year.
- Over the 2024–2025 period, MAIA Biotechnology, Inc.’s net income has grown by 3.7% (from -$23.25 million to -$22.40 million).
- The most recent figure is from MAIA Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: